- Advertisement -spot_imgspot_imgspot_imgspot_img
HomeBusinessAfrica Falls Short In WHO’s Readiness for COVID-19 Vaccination Drive

Africa Falls Short In WHO’s Readiness for COVID-19 Vaccination Drive

- Advertisement -spot_img

By Babajide Okeowo

With an average score of 33% readiness for a COVID-19 vaccine roll-out which is well below the desired benchmark of 80%, a new World Health Organization (WHO) analysis finds that Africa is far from ready for what will be the continent’s largest-ever immunization drive.

Dr. Matshidiso Moeti, WHO Regional Director for Africa made this known during a virtual press conference facilitated by APO Group. She was joined by Professor Helen Rees, Executive Director, Wits Reproductive Health and HIV Institute at the University of the Witwatersrand, Chairperson, African Regional Immunization Technical Advisory Group (RITAG), and Chairperson of the South African Health Products Regulatory Authority. Other speakers were Professor Pontiano Kaleebu, Director Uganda Virus Research Institute (UVRI) and MRC/UVRI and London School of Hygiene and Tropical Medicine Uganda Research Unit; and Professor Fredrick N Were, Perinatal & Neonatal Medicine, University of Nairobi and Chief Research Scientist, Kenya Paediatric Research Consortium.

“The largest immunization drive in Africa’s history is right around the corner, and African governments must urgently ramp up readiness. Planning and preparation will make or break this unprecedented endeavor, and we need active leadership and engagement from the highest levels of government with solid, comprehensive national coordination plans and systems put in place,” she said.

All 47 countries in the WHO African Region have received WHO’s Vaccine Readiness Assessment Tool which is intended to be used by Ministries of Health, with support from WHO and UNICEF. It provides a roadmap for countries to plan for COVID-19 vaccine introduction and covers 10 key areas: planning and coordination, resources and funding, vaccine regulations, service delivery, training and supervision, monitoring and evaluation, vaccine logistics, vaccine safety, and surveillance and communications and community engagement with forty countries updating the tool and provided data to WHO.

“Developing a safe and effective vaccine is just the first step in a successful rollout. If communities are not onboard and convinced that a vaccine will protect their health, we will make little headway. It’s critical that countries reach out to communities and hear their concerns and give them a voice in the process” said Dr. Moeti.

WHO estimates the cost of rolling out a COVID-19 vaccine on the African continent to priority populations will be around US$ 5.7 billion. This does not include an additional 15% – 20% cost for injection materials and the delivery of vaccines, which require trained health workers, supply chain and logistics, and community mobilization. This cost is based on COVAX facility estimates of the average vaccine price at US$ 10.55 per dose and that a two-dose regimen will be needed.

WHO and partners recently released guidance on COVID-19 vaccination planning and deployment for national governments, aiming to help them design strategies for the deployment, implementation, and monitoring of COVID-19 vaccines and better integrate their strategies and financing to boost efficiency.
- Advertisement -spot_img
- Advertisement -spot_img
Stay Connected
Must Read
- Advertisement -spot_img
Related News
- Advertisement -spot_img


Please enter your comment!
Please enter your name here